{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:37:27Z","timestamp":1759451847466,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007173","name":"Bio-oriented Technology Research Advancement Institution","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007173","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institute of Tropical Medicine at Nagasaki University"},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology, Japan","doi-asserted-by":"crossref","award":["20590425","23590490"],"award-info":[{"award-number":["20590425","23590490"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.vaccine.2011.11.059","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T16:31:37Z","timestamp":1322843497000},"page":"948-958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice"],"prefix":"10.1016","volume":"30","author":[{"given":"Takeshi","family":"Miyata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Harakuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toki","family":"Taira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"May (4674)","key":"10.1016\/j.vaccine.2011.11.059_bib0005","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/1831533a0","article-title":"Enterotoxicity of bacteria-free culture-filtrate of Vibrio cholerae","volume":"183","author":"De","year":"1959","journal-title":"Nature"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2011.11.059_bib0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3181\/00379727-132-34318","article-title":"Pathogenesis of experimental cholera: choleragen-induced rat foot edema; a method of screening anticholera drugs","volume":"132","author":"Finkelstein","year":"1969","journal-title":"Proc Soc Exp Biol Med"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2011.11.059_bib0015","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00018-008-7496-5","article-title":"Cholera toxin structure, gene regulation and pathophysiological and immunological aspects","volume":"65","author":"Sanchez","year":"2008","journal-title":"Cell Mol Life Sci: CMLS"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.11.059_bib0020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/infdis\/149.6.884","article-title":"Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine","volume":"149","author":"Svennerholm","year":"1984","journal-title":"J Infect Dis"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2011.11.059_bib0025","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1073\/pnas.79.9.2976","article-title":"Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12","volume":"79","author":"Pearson","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2011.11.059_bib0030","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1093\/nar\/10.16.4883","article-title":"The expression of biologically active cholera toxin in Escherichia coli","volume":"10","author":"Gennaro","year":"1982","journal-title":"Nucleic Acids Res"},{"issue":"December (13)","key":"10.1016\/j.vaccine.2011.11.059_bib0035","first-page":"1574","article-title":"Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccines","volume":"11","author":"Lebens","year":"1993","journal-title":"Biotechnology (NY)"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.11.059_bib0040","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1073\/pnas.86.2.481","article-title":"Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development","volume":"86","author":"Sanchez","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"August (2\u20133)","key":"10.1016\/j.vaccine.2011.11.059_bib0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1574-6968.1993.tb06389.x","article-title":"Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis","volume":"111","author":"Ichikawa","year":"1993","journal-title":"FEMS Microbiol Lett"},{"issue":"April (20)","key":"10.1016\/j.vaccine.2011.11.059_bib0050","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0264-410X(99)00337-0","article-title":"Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant","volume":"18","author":"Goto","year":"2000","journal-title":"Vaccine"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.11.059_bib0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbrc.2004.01.037","article-title":"High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha","volume":"315","author":"Song","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.11.059_bib0060","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1128\/IAI.73.9.5654-5665.2005","article-title":"Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems","volume":"73","author":"Harakuni","year":"2005","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.11.059_bib0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nbt0398-292","article-title":"Efficacy of a food plant-based oral cholera toxin B subunit vaccine","volume":"16","author":"Arakawa","year":"1998","journal-title":"Nat Biotechnol"},{"issue":"June (26)","key":"10.1016\/j.vaccine.2011.11.059_bib0070","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1073\/pnas.0703766104","article-title":"Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination","volume":"104","author":"Nochi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.11.059_bib0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11248-008-9205-4","article-title":"Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (As16) of Ascaris suum fused with cholera toxin B subunit","volume":"18","author":"Matsumoto","year":"2009","journal-title":"Transgenic Res"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.11.059_bib0080","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1128\/IAI.69.9.5716-5725.2001","article-title":"Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells","volume":"69","author":"George-Chandy","year":"2001","journal-title":"Infect Immun"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.11.059_bib0085","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/IAI.00306-10","article-title":"Plasmodium vivax ookinete surface protein Pvs25 linked to cholera toxin B subunit induces potent transmission-blocking immunity by intranasal as well as subcutaneous immunization","volume":"78","author":"Miyata","year":"2010","journal-title":"Infect Immun"},{"issue":"December (2)","key":"10.1016\/j.vaccine.2011.11.059_bib0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-1759(97)00170-1","article-title":"Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding","volume":"210","author":"Liljeqvist","year":"1997","journal-title":"J Immunol Methods"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2011.11.059_bib0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2004.11.009","article-title":"Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA","volume":"97","author":"Holmgren","year":"2005","journal-title":"Immunol Lett"},{"issue":"May (1\u20132)","key":"10.1016\/j.vaccine.2011.11.059_bib0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-1759(00)00290-8","article-title":"Expression of single-chain Fv\u2013Fc fusions in Pichia pastoris","volume":"251","author":"Powers","year":"2001","journal-title":"J Immunol Methods"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.11.059_bib0105","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1128\/iai.65.12.4984-4988.1997","article-title":"Production of Vibrio cholerae accessory cholera enterotoxin (Ace) in the yeast Pichia pastoris","volume":"65","author":"Trucksis","year":"1997","journal-title":"Infect Immun"},{"issue":"February (2\u20133)","key":"10.1016\/j.vaccine.2011.11.059_bib0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-1656(99)00201-1","article-title":"Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris","volume":"77","author":"Hardy","year":"2000","journal-title":"J Biotechnol"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2011.11.059_bib0115","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/S0264-410X(02)00701-6","article-title":"Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials","volume":"21","author":"Zou","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.11.059_bib0120","first-page":"39","article-title":"An in vivo assay for the detection of cytotoxic strains of Escherichia coli","volume":"20","author":"De Rycke","year":"1989","journal-title":"Ann Rech Vet"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.11.059_bib0125","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1128\/IAI.05214-11","article-title":"Tricomponent immunopotentiating system as a novel molecular design strategy for malaria vaccine development","volume":"79","author":"Miyata","year":"2011","journal-title":"Infect Immun"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2011.11.059_bib0130","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1074\/jbc.271.11.6363","article-title":"The amino acid at the X position of an Asn-X-Ser sequon is an important determinant of N-linked core-glycosylation efficiency","volume":"271","author":"Shakin-Eshleman","year":"1996","journal-title":"J Biol Chem"},{"issue":"April (5)","key":"10.1016\/j.vaccine.2011.11.059_bib0135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/protein\/3.5.433","article-title":"Sequence differences between glycosylated and non-glycosylated Asn-X-Thr\/Ser acceptor sites: implications for protein engineering","volume":"3","author":"Gavel","year":"1990","journal-title":"Protein Eng"},{"issue":"August (17)","key":"10.1016\/j.vaccine.2011.11.059_bib0140","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1021\/bi00338a028","article-title":"Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F","volume":"24","author":"Tarentino","year":"1985","journal-title":"Biochemistry (Mosc)"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.11.059_bib0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0304-4165(98)00126-3","article-title":"Overview of N- and O-linked oligosaccharide structures found in various yeast species","volume":"1426","author":"Gemmill","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2011.11.059_bib0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/yea.320050206","article-title":"Size distribution and general structural features of N-linked oligosaccharides from the methylotrophic yeast, Pichia pastoris","volume":"5","author":"Grinna","year":"1989","journal-title":"Yeast"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2011.11.059_bib0155","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1021\/bi972217k","article-title":"The amino acid following an asn-X-Ser\/Thr sequon is an important determinant of N-linked core glycosylation efficiency","volume":"37","author":"Mellquist","year":"1998","journal-title":"Biochemistry (Mosc)"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.11.059_bib0160","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0092-8674(83)90070-3","article-title":"Yeast alpha factor is processed from a larger precursor polypeptide: the essential role of a membrane-bound dipeptidyl aminopeptidase","volume":"32","author":"Julius","year":"1983","journal-title":"Cell"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2011.11.059_bib0165","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4049\/jimmunol.163.2.1045","article-title":"Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice","volume":"163","author":"Sun","year":"1999","journal-title":"J Immunol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.11.059_bib0170","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nbt1098-934","article-title":"A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes","volume":"16","author":"Arakawa","year":"1998","journal-title":"Nat Biotechnol"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2011.11.059_bib0175","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2011.11.059_bib0180","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.4049\/jimmunol.176.8.4902","article-title":"Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin","volume":"176","author":"Adamsson","year":"2006","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101855X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101855X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:18:26Z","timestamp":1759400306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1101855X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0264410X1101855X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}